Charles G. Hadley

Founder at Replication Medical, Inc.

Charles G. Hadley

Charles G. Hadley

Founder at Replication Medical, Inc.

Overview
Career Highlights

Imatron, Inc.
Mid-Atlantic Capital Alliance
Replication Medical, Inc.

RelSci Relationships

219

Number of Boards

12

Relationships
RelSci Relationships are individuals Charles G. Hadley likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Bioconnect Systems, Inc.

Relationship likelihood: Strong

Co-Founder at Cardinal Partners

Relationship likelihood: Strong

Secretary & Director at Myvu Corp.

Relationship likelihood: Strong

President & Chief Executive Officer at Replication Medical, Inc.

Relationship likelihood: Strong

Co-Founder at Bioconnect Systems, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Director at Prescription Advisory Systems & Technology, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Trice Medical, Inc.

Relationship likelihood: Strong

Co-Founder at Cardinal Partners

Relationship likelihood: Strong

Co-Founder at Cardinal Partners

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Endius, Inc.

Relationship likelihood: Strong

Paths to Charles G. Hadley
Potential Connections via
Relationship Science
You
Charles G. Hadley
Founder at Replication Medical, Inc.
Education
Graduate
Class of 1978

The George Washington University actively engages Washington, D.C., and the world. Their location in the heart of Washington places them at the core of U.S. government, policy and law. They sit where the worlds of science, technology, media and the arts converge. Their students and faculty have the unparalleled opportunity to study and work alongside leaders and practitioners in every discipline, to take part in the interchanges that shape our community and the world. The George Washington University was created in 1821 through an Act of Congress, fulfilling George Washington’s vision of an institution in the nation’s capital dedicated to educating and preparing future leaders. Today, GW is the largest institution of higher education in the District of Columbia. They have more than 20,000 students—from all 50 states, the District and more than 130 countries—studying a rich range of disciplines: from forensic science and creative writing to international affairs and computer engineering, as well as medicine, public health, the law and public policy. GW comprises three campuses—Foggy Bottom and Mount Vernon in Washington, D.C., and the GW Virginia Science and Technology Campus in Ashburn, Va.—as well as several graduate education centers in the metropolitan area and Hampton Roads, Va.

MBA

The Stanford Graduate School of Business has built an international reputation based on its innovative programs, which include: Two-year MBA Program, designed to educate business leaders One-year Stanford Sloan Master’s Program for mid-career executives PhD Program for future academics Executive Education programs for experienced managers Faculty research program Academic programs, including the two-year MBA, the 12-month Sloan Master's Program, and the PhD program, create a transformational student experience that reflects the tagline: Change lives. Change organizations. Change the world. Today the state-of-the-art Knight Management Center complex enables Stanford's innovative, globalized MBA curriculum, offering flexible classroom spaces for hands-on experiential learning small-group leadership labs, and team-based learning. It engages faculty and students across Stanford University, as well as alumni, global executives, and the broader world community.

JD

Stanford began offering a curriculum in legal studies in 1893, when the university engaged its first two law professors. One was Benjamin Harrison, former President of the United States, who delivered a landmark series of lectures on the Constitution. The other was Nathan Abbott, who served as head of the nascent law program. Abbott assembled a small faculty to which he imparted a standard of rigor and excellence that endures to this day.In an effort to acknowledge the emerging professional nature of the department, Stanford's Board of Trustees passed a resolution in 1908 to substitute the term 'law school' for 'law department,' though technically the law program remained a department within the university.The law school was at the forefront of efforts to institute the California Bar exam, which was added to the requirements to practice law in California in 1919. The law school was accredited by the American Bar Association in 1923, the year the ABA began certifying law schools.

Career History
Advisor
2007 - Current

Cardinal Partners focuses exclusively on healthcare investments including the life sciences, medical devices and healthcare information technology. The firm specializes in early-stage financing rounds, usually as the lead investor in the initial financing round of a growth company. Investments generally range from $6 million to $12 million per company. Cardinal Partners targets companies that: (1) operate in large or fast-growing markets (2) have a strong CEO, founder, team or scientist (3) possess a proprietary intellectual asset or novel technology and (4) have a well-defined business model.

Founder
2000 - Current

Replication Medical, Inc. develops implantable hydrogel devices. Its products include Enguard, Gelguard, GelFix and GelStix. The company was founded by Vladimir A. Stoy, Chuck G. Hadley and David W. Anderson in 2000 and is headquartered Cranbury, NJ.

Founder
Current

Part of Esperion Therapeutics, Inc., Talaria Therapeutics, Inc. is an American company located in West Conshohocken, PA, involved in commercial physical and biological research. The firm was founded by Chuck G. Hadley and Dennis I. Goldberg. On 05 Oct 00 Esperion Therapeutics, Inc. acquired Talaria Therapeutics, Inc. for $18.65 million.

Boards & Committees
Chairman
2000 - Current

Replication Medical, Inc. develops implantable hydrogel devices. Its products include Enguard, Gelguard, GelFix and GelStix. The company was founded by Vladimir A. Stoy, Chuck G. Hadley and David W. Anderson in 2000 and is headquartered Monmouth Junction, NJ.

Chairman
Current

Bioconnect Systems, Inc. provides surgical implants and techniques that form controlled vascular connections. It offers Optiflow, a family of anastomotic connectors that provides repeatable method for connecting vessels. The company was founded by Michael Dugery and Adam D. Dakin on May 8, 2006 and is headquartered in Ambler, PA.

Executive Chairman
Current

Active Protective Technologies, Inc. develops medical technology solutions. It provides a smartbelt that can determine a human fall, and deploys airbags to protect the hips of older adults. The device also has all functionality of medical alert pendants, and will therefore wirelessly alert caregivers. The company was founded by Drew Lakatos and Robert F. Buckman and is headquartered in Philadelphia, PA.

Member, Investment Advisory Board
Prior

Ben Franklin Technology Partners of Southeastern Pennsylvania engages in investment and advisory services. It provides capital to information technology, health, manufacturing, energy, and physical sciences industries. The company is headquartered in Philadelphia, PA.

Political Donations
$2,500
2013

Former Representative from Pennsylvania's 7th Congressional District

$1,000
2012
$500
2012

Former President of United States

Investments
Details Hidden

Replication Medical, Inc. develops implantable hydrogel devices. Its products include Enguard, Gelguard, GelFix and GelStix. The company was founded by Vladimir A. Stoy, Chuck G. Hadley and David W. Anderson in 2000 and is headquartered Cranbury, NJ.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Charles G. Hadley. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Charles G. Hadley's profile does not indicate a business or promotional relationship of any kind between RelSci and Charles G. Hadley.